Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ventricular arrhythmias.

K M Kavanagh1, D G Wyse

  • 1Department of Medicine, University of Calgary, Alta.

CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|May 15, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy of amiodarone in patients with atrial fibrillation with and without left ventricular dysfunction: a pooled analysis of AFFIRM and AF-CHF trials.

Journal of cardiovascular electrophysiology·2014
Same author

Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial.

Lancet (London, England)·2008
Same author

Rate control versus rhythm control--decision making.

The Canadian journal of cardiology·2005
Same author

Management of atrial fibrillation.

Current problems in cardiology·2005
Same author

Life threatening ventricular arrhythmias with transient or correctable causes.

Minerva cardioangiologica·2003
Same author

International consensus on nomenclature and classification of atrial fibrillation; a collaborative project of the Working Group on Arrhythmias and the Working Group on Cardiac Pacing of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2003
Same journal

Rheumatoid synovitis of the elbow mimicking rheumatoid nodule.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2026
Same journal

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2026
Same journal

What pool closures in Canada mean for health.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2026
Same journal

Fatal rabies in a child.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2026
Same journal

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2026
Same journal

Otitis externa.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2026
See all related articles

Sudden cardiac death is a major concern, with ventricular tachycardia and fibrillation causing most deaths. Identifying high-risk patients, especially those with structural heart issues, is crucial for effective intervention and treatment strategies.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Sudden Cardiac Death Research

Background:

  • Sudden cardiac death (SCD) affects thousands of Canadians annually, with ventricular tachycardia (VT) and ventricular fibrillation (VF) responsible for up to 85% of these fatalities.
  • Identifying individuals at high risk for SCD remains a significant clinical challenge, with current focus on patients with a history of recurrent VT or resuscitation from VF.

Purpose of the Study:

  • To review the risk stratification for sudden cardiac death, particularly in the context of ventricular arrhythmias.
  • To discuss the management strategies for patients at risk of sudden cardiac death, including treatment indications and therapeutic options.

Main Methods:

  • Review of existing literature and clinical guidelines concerning ventricular arrhythmias and sudden cardiac death.

Related Experiment Videos

  • Discussion of electrophysiologic features and antiarrhythmic drug classification in guiding treatment selection.
  • Emphasis on individualized therapy based on drug efficacy, patient's left ventricular function, and potential adverse effects.

    • Main Results:

    • Ventricular premature beats may indicate increased SCD risk when associated with structural cardiac abnormalities, especially recent myocardial infarction, though treatment necessity is under investigation.
    • Mandatory treatment is indicated for survivors of ventricular fibrillation and patients with recurrent sustained VT or torsade de pointes VT.
    • Management approaches include invasive and noninvasive strategies, with antiarrhythmic drug selection guided by electrophysiologic properties and patient-specific factors.

    Conclusions:

    • Risk stratification for SCD requires careful consideration of patient history, including previous arrhythmias and presence of structural heart disease.
    • Treatment decisions for ventricular arrhythmias must be individualized, balancing efficacy, safety, and patient characteristics.
    • Amiodarone or nonpharmacologic therapies are important alternatives when standard antiarrhythmic agents are unsuitable.